Home
Live
News
Create
Screeners
Insights
Supriya Lifescience
651.
55
-4.05
(-0.62%)
Market Cap
₹5,243.86 Cr
PE Ratio
29.63
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.62%
1M
-1.02%
6M
+5.12%
1Y
+11.61%
5Y
+66.70%
View Company Insights
Latest news about Supriya Lifescience
Supriya Lifescience Sets Ambitious Growth Targets, Eyes US Market Expansion
6 days ago
Supriya Lifescience has announced a comprehensive growth strategy aiming for 33-35% EBITDA margins by FY26 and Rs 1,000 crore revenue by FY27. The plan includes launching 3-4 new products annually, entering the US market, and investing Rs 200 crore over three years for a new site in Patalganga. The company has already launched a new anaesthetic product and is in talks for a potential blockbuster with a $7 billion market. Supriya is focusing on regulated markets with USFDA-compliant facilities and emphasizing backwards integration to compete effectively against Chinese manufacturers.
Supriya Lifescience Faces ₹603.8 Crore Tax Demand
Jul 01, 2025
Supriya Lifescience Unveils Ambitious Growth Strategy, Targets ₹1,000 Crore Revenue by FY27
May 29, 2025
Supriya Lifescience Reports Strong Q4 Results, Announces Dividend
May 27, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation